基于神经网络的动态预测间隔审查数据与时间变化的共变量:适用于阿尔茨海默病的应用
Kexin Liu1, Yining Zu1, Danhui Yi1
1Center for Applied Statistics and School of Statistics, Renmin University of China, Beijing, China.
Statistics in medicine
|July 18, 2025
概括
这项研究使用先进的统计方法引入了阿尔茨海默病 (AD) 的新动态预测模型. 该模型提高了预测准确性,并识别了处于风险的子组,以便及时进行干预.
科学领域:
- 神经科学是一个神经科学.
- 生物统计学 生物统计学
- 医疗信息学 医疗信息学
背景情况:
- 阿尔茨海默病 (AD) 是导致痴呆的主要原因,没有有效的治疗方法.
- 动态预测模型对于AD的及时干预至关重要.
- 现有模型面临的挑战是间歇性数据和复杂的共同变量效应.
研究的目的:
- 开发一种针对阿尔茨海默病的新型动态预测方法.
- 使用纵向认知和功能数据准确预测AD发展.
- 为个性化干预确定高风险和低风险子组.
主要方法:
- 利用了来自阿尔茨海默病神经成像倡议 (ADNI) 研究 (1702人) 的数据.
- 综合多变量功能主要组件分析 (FPCA) 使用神经网络.
- 针对区间审查的时间到AD,多个时间变化的协变量和非线性效应.
主要成果:
- 与现有方法相比,提出的方法显示出更高的预测准确性.
- 根据进展概况,成功确定了不同的高风险和低风险子组.
- 促进了AD发展的个性化和动态风险预测.
结论:
- 开发的方法提供了对阿尔茨海默病的准确和动态风险预测.
- 能够及早识别需要及时干预的个体.
- 有一个在线平台可用于动态预测的实际应用.
更多相关视频
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
8.0K
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
12.3K
相关概念视频
01:03Prediction Intervals
2.3K
The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
2.3K
01:26Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
01:22Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
01:37Neural Regulation
40.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.1K
01:09Censoring Survival Data
241
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
241
01:15Drug Concentration Versus Time Correlation
1.2K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
1.2K